Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of Palantir Technologies (NasdaqGS:PLTR) with a ...

Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of DigitalOcean Holdings (NYSE:DOCN) with a ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main driver of the rating is the parent firm's five-year risk-adjusted success ratio of 90%. The measure ...

Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...

Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for Nova in a report issued on Monday, January 13th. Cantor Fitzgerald analyst M. Prisco forecasts that the semiconductor ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus (FOLD – Research Report), with a price ...

Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75-million penalty to settle Securities and Exchange Commission charges that it misled investors in blank-check companies it ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

Cantor Fitzgerald, which is run by Donald Trump's pick for Commerce Secretary, has been accused by the Securities and Exchange Commission of misleading investors. AFP Cantor Fitzgerald ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.